School of Pharmacy - Sungkyunkwan UniversitySuwon-si, South Korea
Disclosure information not submitted.
SP02D - The Risk of Serious Infection in Rheumatoid Arthritis Patients Receiving Tocilizumab Compared with Tumor Necrosis Factor Inhibitors in Korea
Tuesday, August 24, 20213:30 PM – 4:45 PM US Eastern Time